Advanced search
Publication Cover
Journal of Pharmaceutical Marketing & Management Volume 14, 2002 - Issue 3-4
Journal homepage
7
Views
0
CrossRef citations to date
0
Altmetric
Original Article

The Economic Contribution of Pharmaceutical Marketing

E. M. Kolassa University of Mississippi School of Pharmacy, University, MS, 38677
Pages 101-108 | Published online: 04 Dec 2011

REFERENCES

  • Drake D, Uhlman M. Making medicine, making money. Kansas City: Andrews and McMeel; 1993.
  • Fagan SC, et al. Cost-effectiveness of Tissues Plasminogen Activator for acute ischemic stroke. Neurol. 1998; 50:883–9.
  • Legg RF, et.al. Cost benefit of sumatriptan to an employer. J Occup Environ Med. 1997; 39:652–7.
  • Peters WP. Comparative effects of G-CSF and PBPC chemotherapy. Blood. 1993; 81:1709–19.
  • Anon. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med. 1991; 325:293–302.
  • Boston Consulting Group. The contribution of pharmaceutical companies: What's at stake for America? Boston: Boston Consulting Group; 1993.
  • Battelle Medical Policy Assessment and Research Center. The value of pharma-ceuticals: An assessment of future costs for selected conditions. Washington, DC: Battelle Human Affairs Research Centers (MEDTAP); 1991.
  • Berndt E. Illness and productivity: Objective workplace evidence. MIT Working Paper; May 1997.
  • Payne JW, Beaman JR, Johnson EJ. The adaptive decision maker. Cambridge, MA: Cambridge University Press; 1993.
  • Fennell ML, Warnecke RB. The diffusion of medical innovation: An applied network analysis. New York: Plenum Press; 1988.
  • Avorn J, Harvey K, Soumerai SB, Herxheimer A, Plumridge R, Bardelay G. In-formation and education as determinants of antibiotic use: Report of Task Force 5. Res Infectious Dis. 1987; 9(3):5286–96.
  • Schwartzman D. Innovation in the pharmaceutical industry. Baltimore: Johns Hopkins University Press; 1976.
  • Kolassa EM. Growing competition in the pharmaceutical industry: A response to the PRIME Institute Report—An academic critique of the PRIME Institute Report, Competition and Pricing Issues in the Pharmaceutical Market. University, MS: Uni-versity of Mississippi Research Institute of Pharmaceutical Sciences; 1995.
  • Davis DA, Fox RD, eds. The physician as learner: Linking research to practice. Chicago: American Medical Association; 1994.
  • Boston Consulting Group. The changing environment for U.S. pharmaceut-icals: The role of pharmaceutical companies in a systems approach to health care: a re-port. New York: Boston Consulting Group; 1993.
  • Nagle TT, Holden RK. The strategy and tactics of pricing. 2nd ed. Englewood Cliffs, NJ: Prentice-Hall; 1995.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.